|CCL 05.11.09 Euro Meeting on Drug Discovery Applications of Cheminformatics and Modelling, Basel, CH|
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Sat Oct 22 00:58:12 2005
Subject: 05.11.09 Euro Meeting on Drug Discovery Applications of Cheminformatics and Modelling, Basel, CH
Conference Center, Basel, Switzerland, November 9-10, 2005 eCheminfo European Autumn 2005 InterAction Meeting The eCheminfo European Autumn 2005 meeting will be taking place at the Swissotel Lentre Conference Center, Basel, Switzerland, November 9-10. Program information and registration is available through the eCheminfo website at http://echeminfo.com/ The theme of the meeting is the application of cheminformatics and chemical modelling to drug discovery and will include the following sessions: Virtual Screening, Docking & Scoring, chaired by Miklos Vargyas (ChemAxon); Web-based Services in Drug Design, chaired by Kim Henrick (European Bioinformatics Institute); Computational Biochemistry, chaired by Alessandro Curioni (IBM Zurich); Applications of Machine Learning & Graph Mining in Drug Discovery, chaired by Stefan Kramer (Technische Universitaet Muenchen); Biosensors & Nanofluidics, Nick Quirke (Imperial College London); Protein Folding and Dynamics, chaired by Wilfred van Gunsteren (ETH-Zurich) Invited Speakers include: Graham Richards (University of Oxford), Xavier Barril (Vernalis), Amedeo Caflisch (ETH-Zurich), David Morley (Enspiral Discovery Ltd), Didier Rognan (University of Strasbourg), Dimitris Dimitropoulos (European Bioinformatics Institute), Johann Gasteiger (Universitaet Erlangen-Nuernberg), Simon Coles (University of Southampton), Eugene Krissinel (European Bioinformatics Institute), Torsten Schwede (University of Basel), Paul Tavan (University of Munich), Ursula Roethlisberger (Swiss Federal Institute of Technology, Lausanne), Alessandro Curioni (IBM Zurich), Ian Williams (University of Bath), Gerald Monard (Universite Henri Poincare - Nancy), Ken Merz (QuantumBio), Nick Quirke (Imperial College London), Richard Gilbert (E2v Technologies), Andrew De Mello (Imperial College London), Jens Walther (ETH-Zurich), Christoph Helma (University of Freiburg), Peter Willett (University of Sheffield), Joost N. Kok (Leiden University), Gisbert Schneider (Johann Wolfgang Goethe-University), Michael Berthold (University of Konstanz), Jeremy Smith (University of Heidelberg), Wolfgang Wenzel (University of Karslruhe), Thomas Kiefhaber (University of Basel), Xavier Daura (University of Barcelona), Nikolay V. Dokholyan (University of North Carolina), Michele Vendruscolo (University of Cambridge) The eCheminfo meetings will have exhibitor tables for software demos and evening poster sessions; posters will also be available for viewing through the website. Posters can be on any informatics or modeling topic of relevance to drug discovery. Those who cannot make the meetings are also able to register to access all presentations with audio and posters through the eCheminfo website. Poster Abstracts (ca. 300 words) should be sent to eCheminfo at douglasconnect.com Papers submitted with either seminar or poster presentations will be refereed for consideration for publication in the Molecular Simulation journal. The InnovationWell European community of practice Autumn meeting will be taking place at the same location and on the same dates as the eCheminfo European meeting. This meeting will be covering semantic web applications in drug discovery and development, life science intellectual property management and valuation; knowledge management and transfer in R&D and manufacturing, clinical trial productivity, drug safety knowledge management and predictive toxicology. All eCheminfo registrants will also have access to the InnovationWell meeting activities. (See http://innovationwell.net/ for more details). Please register early for the meetings as the number of places are limited. You can register for the meeting on the website or contact Nicki Douglas (nicki.douglas at douglasconnect.com, +41 61 851 0461) to reserve your place. What is the eCheminfo Community of Practice? http://echeminfo.com/ eCheminfo is a global Community of Practice (CoP) dedicated to the sharing of research and development of best practices in cheminformatics and chemical modelling of relevance to drug discovery. The CoP involves a diversity of subject matter expertise including experienced professionals from the life science and pharmaceutical industry, vendors, research institutes, universities and government. eCheminfo is committed to the core value of outreach with diverse groups in the commercial, government and academic sectors for the sharing of best practices and the development of strategies, resources and methodologies that address specific issues in improved drug discovery and productivity. Communications activities deploy virtual approaches and a collaboration environment, in addition to regional discussion- and networking-designed face-to-face InterAction meetings. Membership includes access to over 100 seminars from top industry and academic experts, discussion conference calls, and networking facilities. Barry Hardy, PhD Douglas Connect, Switzerland +41 61 851 0170 (office) http://www.douglasconnect.comNOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to  to fight spam. Before you send e-mail, you need to change  to @
For example: change joebig123comp.com to firstname.lastname@example.org
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.
Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!
|Modified: Sat Oct 22 04:58:12 2005 GMT|
|Page accessed 4730 times since Sat Oct 22 04:58:12 2005 GMT|
Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.